AVIXIN ALPHA INJ. 1A

AVIXIN ALPHA INJ s an immune-modulating injection that contains thymosin alpha-1, a naturally occurring peptide involved in T-cell development and immune response regulation. It is used to strengthen immunity, particularly in patients with weakened immune systems due to chronic illness, cancer, or viral infections.

Composition

Thymosin-α1: 1.6 mg

Excipients: D-mannitol, phosphate buffers, water for injection

Benefits

Enhances T-cell and natural killer (NK) cell function

Improves immune response to vaccines (e.g., flu vaccines in elderly)

Adjuvant in cancer immunotherapy (e.g., liver, lung, melanoma)

Helpful in chronic viral infections (like hepatitis B, C, and HIV)

May support recovery in respiratory viral infections

How to Use

Route: Subcutaneous (SC) or Intramuscular (IM) injection

Dose: Typically 1.6 mg (1 vial) twice per week

Duration: Usually 4 weeks (can be extended depending on condition)

Side Effects & Precautions

Usually well-tolerated

Mild redness or irritation at the injection site

Possible: fever, fatigue, joint pain, temporary ALT elevation

Caution in patients with autoimmune diseases or on immunosuppressants

Volume 1 amp

*The product has contraindications. We are not responsible for any negative consequences that you may encounter after self-use of the product. Before any procedure, it is recommended to consult a doctor or medical specialist.